Effect of pioglitazone on L-NAME induced hypertension in diabetic rats

Vascular Pharmacology

Volumn 43, Issue 4, 2005, Pages 260-266

  Majithiya, Jayesh B ^a   Parmar, Arvind N ^a   Trivedi, Chitrang J ^a   Balaraman, R ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Blood pressure; Diabetes; N nitro L arginine methyl ester; Pioglitazone; Streptozotocin

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CATALASE; DRINKING WATER; ENZYME; GLUCOSE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PIOGLITAZONE; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HYPERTENSION; ISOLATED ORGAN; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; MEDICAL RECORD; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RANDOMIZATION; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; THORACIC AORTA; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUTATHIONE; HYPERTENSION; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 27744517720     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.08.012     Document Type: Article

References (29)

1. H. Aebi Oxidoreductases acting on groups other than CHOH: catalase S.P. Colowick N.O. Kaplan L. Packer Methods in Enzymology vol. 105 1984 Academic Press London 121 125
2. P.A Bafna, and R. Balaraman Anti-ulcer and antioxidant activity of DHC-1, a herbal formulation J. Ethnopharmacol. 90 2004 123 127
3. T.A. Buchanan, W.P. Meehan, Y.Y. Jeng, D. Yang, T.M. Chan, J.L. Nadler, S. Scott, R.K. Rude, and W.A. Hsueh Blood pressure lowering by pioglitazone: evidence for a direct vascular effect J. Clin. Invest. 96 1995 354 360
4. K.C. Chang, S.Y. Chung, W.S. Chong, J.S. Suh, S.H. Kim, and H.K. Noh Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats J. Pharmacol. Exp. Ther. 266 1993 992 1000
5. R.K. Dubey, H.Y. Zhang, S.R. Reddy, M.A. Boegehold, and T.A. Kotchen Pioglitazone attenuates hypertension and inhibits growth or renal arteriolar smooth muscle rats Am. J. Physiol. 3265 1993 R726 R732
6. S.M. Fitzgerald, and M.W. Brands Nitric oxide may be required to prevent hypertension at the onset of diabetes Am. J. Physiol: Endocrinol. Metab. 279 2000 E762 E768
7. J.W. Grinsell, C.K. Lardinois, A. Swislocki, R. Gonzalez, J.S. Sare, J.R. Michaels, and G.H. Starich Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat Am. J. Hypertens. 13 2000 370 375
8. A. Gumieniczek Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits Life Sci. 74 2003 553 562
9. Y. Hattori, H. Kawasaki, A. Kazuhiro, and M. Kanno Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta Am. J. Physiol. 261 1991 H1086 H1094
10. H. Ikeda, S. Taketomi, Y. Sugiyamam, Y. Shimura, T. Sohda, K. Meguro, and T. Fujita Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals Arzneim.-Forsch. 40 1990 156 162
11. C. Karasu, G. Ozansoy, O. Bozkurt, D. Erdoga n, and S. Omeroglu Changes in isoprenaline-induced endothelium-dependent and independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E Gen. Pharmacol. 29 1997 561 567
12. C. Karasu, G. Ozansoy, O. Bozkurt, D. Erdogan, and S. Omeroglu Antioxidant and triglyceride lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats Metabolism 46 1997 872 879
13. L.N. Kaufman, M.M. Peterson, and S.M. Smith Hypertension and sympathetic hyperactivity induced in rats by high-fat or -glucose diets Am. J. Physiol: Endocrinol. Metab. 260 1991 E95 E100
14. J.W. Kemnitz, D.F. Elson, E.B. Roecker, S.T. Baum, R.N. Bergman, and M.D. Meglasson Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant Rhesus monkeys Diabetes 43 1994 204 211
15. T.A. Kotchen, S. Reddy, and H.Y. Zhang Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat Am. J. Hypertens. 10 1997 1020 1026
16. J.B. Majithiya, A.N. Paramar, and R. Balaraman Pioglitazone, a PPAR gamma agonist restores endothelial dysfunction in aorta of streptozotocin induced diabetes in rats Cardiovasc. Res. 66 2005 150 161
17. H.P. Mishra, and I. Fridovich The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
18. M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver Biochim. Biophys. Acta 582 1979 67 78
19. G.M. Pieper Oxidative stress in diabetic blood vessels FASEB 9 1995 A98.1 (Abstract)
20. G.M. Pieper Acute amelioration of diabetic endothelial dysfunction with a derivative of nitric oxide synthase cofactor, tetrahydrobiopterin J. Cardiovasc. Pharmacol. 29 1997 8 15
21. G.M. Pieper, and W. Siebeneich Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-desferoxamine J. Cardiovasc. Pharmacol. 30 1997 734 738
22. V. Senses, S. Ozyazgan, E. Ince, M. Tuncdemir, F. Kaya, M. Ozturk, G. Sultuybek, and A.G. Akkan Effect of 5-aminoimidazole-4-carboxamide riboside (AICA-r) on isolated thoracic aorta responses in streptozotocin-diabetic rats J. Basic Clin. Physiol. Pharmacol. 12 2001 227 248
23. T.F. Slater, and B.C. Sawyer The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro Biochem. J. 123 1971 805 814
24. A. Uchida, T. Nakata, T. Hatta, M. Kiyama, T. Kawa, S. Morimoto, S. Miki, J. Moriguchi, K. Nakamura, H. Fujita, H. Itoh, S. Sasaki, S. Takeda, and M. Nakagawa Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR Life Sci. 61-4 1997 455 464
25. S. Uemura, H. Matsushita, W. Li, A.J. Glassford, T. Asagami, K.H. Lee, D.G. Harrison, and P.S. Tsao Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress Circ. Res. 88 2001 1291 1298
26. L.L. Woods, H.L. Mizelle, and J.E. Hall Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback Am. J. Physiol., Renal Fluid Electrolyte Physiol. 252 1987 F65 F71
27. M. Zanetti, J. Sato, Z.S. Katusic, and T. O'Brien Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta Am. J. Physiol 280 2001 H2516 H2523
28. F. Zhang, J.R. Sowers, and J.L. Ram Effects of pioglitazone in calcium channels in vascular smooth muscle Hypertension 24 1994 170 175
29. H.Y. Zhang, S.R. Reddy, and T.A. Kotchen Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity Hypertension 24 1994 106 110